now that repeal and replace is dead, we can figure out what we missed while contemplating healthcare armageddon.
Coventry’s out with the second part of their work comp Drug Trends Report – download it here. This part deals with the differences between managed and unmanaged pharmacy. Good video intro by Nikki Wilson too...
HealtheSystems is rumored to be looking to split the company in two, selling off the PBM and keeping the Ancillary Benefit Network business. With myMatrixx setting yet another high point for valuation recently, we’ll have to see if PBM prices remain stratospheric or drop a little closer to earth.
Given the myMatrixx – Express Scripts transaction had a ton of strategic benefit for the acquirer, a similar valuation for Healthe might be a tad optimistic. In addition, a very sizable chunk of the PBM business comes from one payer – the Travelers – a “customer concentration” issue that will give some pause.
BTW, I’m hearing optimism from many work comp pharma buyers about the “new” myMatrixx-ESI combination. Guarded, but optimistic.
Are you seeing an uptick in Commercial Repayment Center (CRC) demands coming from the Coordination of Benefits & Recovery Program? (COB&R)? A couple clients have mentioned this to me..the concern seems to be CMS is revisiting MSAs and looking for additional funds (I am likely not phrasing this correctly…Rafael, please clarify/correct!)
Physicians work for others…
About 2/3rds of younger physicians are employed. Overall, less than half of practicing physicians have an ownership stake in their practice.
Finally, here’s a really interesting snapshot of price variation in a wide variety of healthcare markets…